Development of a New RNA Therapeutic for the Treatment of SYNGAP1 Haploinsuffiency

• Principal Investigator: Jeff Coller, PhD
• Institution: Johns Hopkins University
• Grant Number: 2025.007
• Funding Amount: $260,000.00
• Percentage Dispersed: 50%
• Grant Status: Signed & Active

Press Release pending.
Previous Grant from CURE SYNGAP1: 2022.7